Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...

After threatening to impose “25% or higher” tariffs on foreign-made pharmaceuticals along with automobiles and semiconductors ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...

Discover how pharmaceutical industry-funded drug trials are creating jobs and driving economic growth in the Buckeye State.

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.